Stocks To Watch Today: NALCO, Hindalco, Zydus Life, Manappuram Finance, Glenmark, Thyrocare, PI Industries And More
Positive Triggers
- NALCO & Hindalco: Norsk Hydro announced a 50% curtailment of alumina production, potentially supporting global alumina prices.
- Zydus Lifesciences: Sentynl acquired commercialization rights for a rare respiratory drug in the US market.
- Manappuram Finance: Gold AUM surged nearly 98% year-on-year, indicating strong demand in the gold loan business.
- Glenmark Pharma: US subsidiary settled litigation with Humana, removing a key overhang.
- RHI Magnesita: Strong earnings performance with margin expansion.
- TD Power Systems: Robust revenue and EBITDA growth supported by strong execution.
- Gujarat Industries Power: Significant improvement in profitability and margins.
- Landmark Cars: Reported healthy revenue and EBITDA growth.
- HG Infra: Received Letter of Award from Rajasthan Government.
- Ashok Leyland & JBM Auto: Government may introduce a dedicated incentive scheme for electric trucks and buses.
- MCX: Positive sentiment after regulatory developments regarding FPI participation.
- JSW Dulux: Board approved a 1:10 stock split.
- Saatvik Green: Secured solar module supply orders worth over ₹400 crore.
- Polyplex Corporation: Continued operational improvement with strong revenue growth.
Negative Triggers
- Tata Group Stocks: Reports suggest N. Chandrasekaran may step down as Tata Sons Chairman ahead of the AGM.
- Godrej Consumer Products (GCPL): Sudhir Sitapati resigned as Managing Director and CEO.
- PI Industries: EBITDA and margins declined sharply year-on-year.
- Ashoka Buildcon: Significant contraction in profitability and margins.
- Senco Gold: Profitability remained under pressure despite strong revenue growth.
- Dr Agarwal's Health Care: Large stake sale through block deals may create supply pressure.
- Tenneco: Promoter group plans to reduce stake through block deals.
- Delta Corp: Revenue and margins remained weak with continued earnings pressure.
- Linde India: Margin contraction impacted overall profitability.
- Thyrocare: Large block deal worth around ₹1,000 crore expected in the market.
Written by Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
Read Free content at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.